|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Otsuki N, Konno T, Kurahashi T, Suzuki S,
Lee J, Okada F, Iuchi Y, Homma T and Fujii J: The SOD1 transgene
expressed in erythroid cells alleviates fatal phenotype in congenic
NZB/NZW-F1 mice. Free Radic Res. 50:793–800. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie LP, Chen QX, Huang H, Liu XD, Chen HT
and Zhang RQ: Inhibitory effects of cupferron on the monophenolase
and diphenolase activity of mushroom tyrosinase. Int J Biochem Cell
Biol. 35:1658–1666. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Brown KA, Aakre ME, Gorska AE, Price JO,
Eltom SE, Pietenpol JA and Moses HL: Induction by transforming
growth factor-beta1 of epithelial to mesenchymal transition is a
rare event in vitro. Breast Cancer Res. 6:R215–R231. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen K and Rajewsky N: The evolution of
gene regulation by transcription factors and microRNAs. Nat Rev
Genet. 8:93–103. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wei F, Liu Y, Guo Y, Xiang A, Wang G, Xue
X and Lu Z: miR-99b-targeted mTOR induction contributes to
irradiation resistance in pancreatic cancer. Mol Cancer. 12:812013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mu N, Gu J, Huang T, Zhang C, Shu Z, Li M,
Hao Q, Li W, Zhang W, Zhao J, et al: A novel NF-κB/YY1/microRNA-10a
regulatory circuit in fibroblast-like synoviocytes regulates
inflammation in rheumatoid arthritis. Sci Rep. 6:200592016.
View Article : Google Scholar
|
|
9
|
Wu W, He C, Liu C, Cao AT, Xue X,
Evans-Marin HL, Sun M, Fang L, Yao S, Pinchuk IV, et al: miR-10a
inhibits dendritic cell activation and Th1/Th17 cell immune
responses in IBD. Gut. 64:1755–1764. 2015. View Article : Google Scholar
|
|
10
|
Nikaki A, Piperi C and Papavassiliou AG:
Role of microRNAs in gliomagenesis: Targeting miRNAs in
glioblastoma multiforme therapy. Expert Opin Investig Drugs.
21:1475–1488. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Costa PM, Cardoso AL, Mano M and de Lima
MC: MicroRNAs in glioblastoma: Role in pathogenesis and
opportunities for targeted therapies. CNS Neurol Disord Drug
Targets. 14:222–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang W, Yu H, Shen Y, Liu Y, Yang Z and
Sun T: MiR-146b-5p overexpression attenuates stemness and
radioresistance of glioma stem cells by targeting
HuR/lincRNA-p21/β-catenin pathway. Oncotarget. 7:41505–41526.
2016.PubMed/NCBI
|
|
13
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nakata K, Ohuchida K, Mizumoto K,
Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima
S, et al: MicroRNA-10b is overexpressed in pancreatic cancer,
promotes its invasiveness, and correlates with a poor prognosis.
Surgery. 150:916–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mussnich P, D'Angelo D, Leone V, Croce CM
and Fusco A: The High Mobility Group A proteins contribute to
thyroid cell transformation by regulating miR-603 and miR-10b
expression. Mol Oncol. 7:531–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gabriely G, Yi M, Narayan RS, Niers JM,
Wurdinger T, Imitola J, Ligon KL, Kesari S, Esau C, Stephens RM, et
al: Human glioma growth is controlled by microRNA-10b. Cancer Res.
71:3563–3572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma L, Reinhardt F, Pan E, Soutschek J,
Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW and Weinberg RA:
Therapeutic silencing of miR-10b inhibits metastasis in a mouse
mammary tumor model. Nat Biotechnol. 28:341–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teplyuk NM, Uhlmann EJ, Wong AH, Karmali
P, Basu M, Gabriely G, Jain A, Wang Y, Chiocca EA, Stephens R, et
al: MicroRNA-10b inhibition reduces E2F1-mediated transcription and
miR-15/16 activity in glioblastoma. Oncotarget. 6:3770–3783. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Teplyuk NM, Uhlmann EJ, Gabriely G,
Volfovsky N, Wang Y, Teng J, Karmali P, Marcusson E, Peter M, Mohan
A, et al: Therapeutic potential of targeting microRNA-10b in
established intracranial glioblastoma: First steps toward the
clinic. EMBO Mol Med. 8:268–287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gabriely G, Teplyuk NM and Krichevsky AM:
Context effect: microRNA-10b in cancer cell proliferation, spread
and death. Autophagy. 7:1384–1386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang M, Kleber S, Röhrich M, Timke C, Han
N, Tuettenberg J, Martin-Villalba A, Debus J, Peschke P, Wirkner U,
et al: Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor
LY2109761 enhances radiation response and prolongs survival in
glioblastoma. Cancer Res. 71:7155–7167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Joseph JV, Conroy S, Tomar T,
Eggens-Meijer E, Bhat K, Copray S, Walenkamp AM, Boddeke E,
Balasubramanyian V, Wagemakers M, et al: TGF-β is an inducer of
ZEB1-dependent mesenchymal transdifferentiation in glioblastoma
that is associated with tumor invasion. Cell Death Dis.
5:e14432014. View Article : Google Scholar
|
|
23
|
Duan R, Han L, Wang Q, Wei J, Chen L,
Zhang J, Kang C and Wang L: HOXA13 is a potential GBM diagnostic
marker and promotes glioma invasion by activating the Wnt and TGF-β
pathways. Oncotarget. 6:27778–27793. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lv S, Qin J, Yi R, Coreman M, Shi R, Kang
H and Yao C: CrkL efficiently mediates cell proliferation,
migration, and invasion induced by TGF-β pathway in glioblastoma. J
Mol Neurosci. 51:1046–1051. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xiong M, Jiang L, Zhou Y, Qiu W, Fang L,
Tan R, Wen P and Yang J: The miR-200 family regulates
TGF-β1-induced renal tubular epithelial to mesenchymal transition
through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J
Physiol Renal Physiol. 302:F369–F379. 2012. View Article : Google Scholar
|
|
27
|
Hardee ME, Marciscano AE, Medina-Ramirez
CM, Zagzag D, Narayana A, Lonning SM and Barcellos-Hoff MH:
Resistance of glioblastoma-initiating cells to radiation mediated
by the tumor microenvironment can be abolished by inhibiting
transforming growth factor-β. Cancer Res. 72:4119–4129. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Joseph JV, Balasubramaniyan V, Walenkamp A
and Kruyt FAE: TGF-β as a therapeutic target in high grade gliomas
- promises and challenges. Biochem Pharmacol. 85:478–485. 2013.
View Article : Google Scholar
|
|
29
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Soengas MS, Alarcón RM, Yoshida H, Giaccia
AJ, Hakem R, Mak TW and Lowe SW: Apaf-1 and caspase-9 in
p53-dependent apoptosis and tumor inhibition. Science. 284:156–159.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fang M, Zhong XY, Du B, Lin CL, Luo F,
Tang LJ and Chen J: Role of DJ-1-induced PTEN down-regulation in
migration and invasion of human glioma cells. Chin J Cancer.
29:988–994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gallego O: Nonsurgical treatment of
recurrent glioblastoma. Curr Oncol. 22:e273–e281. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wahl SM, Hunt DA, Wong HL, Dougherty S,
McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G,
Roberts AB, et al: Transforming growth factor-beta is a potent
immunosuppressive agent that inhibits IL-1-dependent lymphocyte
proliferation. J Immunol. 140:3026–3032. 1988.PubMed/NCBI
|
|
34
|
Letterio JJ and Roberts AB: Regulation of
immune responses by TGF-beta. Annu Rev Immunol. 16:137–161. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kehrl JH, Thevenin C, Rieckmann P and
Fauci AS: Transforming growth factor-beta suppresses human B
lymphocyte Ig production by inhibiting synthesis and the switch
from the membrane form to the secreted form of Ig mRNA. J Immunol.
146:4016–4023. 1991.PubMed/NCBI
|
|
36
|
Li MO, Wan YY, Sanjabi S, Robertson AK and
Flavell RA: Transforming growth factor-beta regulation of immune
responses. Annu Rev Immunol. 24:99–146. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qin H, Wang L, Feng T, Elson CO, Niyongere
SA, Lee SJ, Reynolds SL, Weaver CT, Roarty K, Serra R, et al:
TGF-beta promotes Th17 cell development through inhibition of
SOCS3. J Immunol. 183:97–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Curiel TJ, Coukos G, Zou L, Alvarez X,
Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L,
Burow M, et al: Specific recruitment of regulatory T cells in
ovarian carcinoma fosters immune privilege and predicts reduced
survival. Nat Med. 10:942–949. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
39
|
deLeeuw RJ, Kost SE, Kakal JA and Nelson
BH: The prognostic value of FoxP3+ tumor-infiltrating
lymphocytes in cancer: A critical review of the literature. Clin
Cancer Res. 18:3022–3029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang Y, Woosley AN, Sivalingam N,
Natarajan S and Howe PH: Cathepsin-B-mediated cleavage of
disabled-2 regulates TGF-β-induced autophagy. Nat Cell Biol.
18:851–863. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Akhurst RJ and Derynck R: TGF-beta
signaling in cancer - a double-edged sword. Trends Cell Biol.
11:S44–S51. 2001.PubMed/NCBI
|
|
42
|
Knirsh R, Ben-Dror I, Modai S, Shomron N
and Vardimon L: MicroRNA 10b promotes abnormal expression of the
proto-oncogene c-Jun in metastatic breast cancer cells. Oncotarget.
7:59932–59944. 2016.PubMed/NCBI
|
|
43
|
Bahena-Ocampo I, Espinosa M,
Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A,
Garcia-Lopez P, Maldonado V and Melendez-Zajgla J: miR-10b
expression in breast cancer stem cells supports self-renewal
through negative PTEN regulation and sustained AKT activation. EMBO
Rep. 17:10812016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zou D, Zhou Q, Wang D, Guan L, Yuan L and
Li S: The Downregulation of MicroRNA-10b and its role in cervical
cancer. Oncol Res. 24:99–108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vychytilova-Faltejskova P, Pesta M, Radova
L, Liska V, Daum O, Kala Z, Svoboda M, Kiss I and Slaby O:
Genome-wide microRNA expression profiling in primary tumors and
matched liver metastasis of patients with colorectal cancer. Cancer
Genomics Proteomics. 13:311–316. 2016.PubMed/NCBI
|
|
46
|
Wang Y, Li Z, Zhao X, Zuo X and Peng Z:
miR-10b promotes invasion by targeting HOXD10 in colorectal cancer.
Oncol Lett. 12:488–494. 2016.PubMed/NCBI
|
